Related Experiment Video
Updated: Jul 1, 2025

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
Published on: May 8, 2021
Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data.
Carl-Fredrik Burman1,2, Erik Hermansson1, David Bock1
1Early Biometrics & Statistical Innovation, Data Science & Artificial Intelligence, R&D, AstraZeneca, Gothenburg, Sweden.
Bayesian dynamic borrowing (BDB) and digital twins (DT) use historical data in clinical trials. While DT shows promise, BDB may inflate type 1 errors, requiring careful consideration for real-world applications.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Health Informatics
Background:
- Increasing interest in using external control data for randomized clinical trials (RCTs).
- Potential benefits include reduced costs, shorter trial durations, and feasibility for small populations.
- Bayesian dynamic borrowing (BDB) and Digital Twins (DT) are emerging methods for historical data utilization.
Purpose of the Study:
- To analyze and compare Bayesian dynamic borrowing (BDB) and Digital Twins (DT) methods for RCTs.
- To evaluate their performance using analytic derivations and simulations.
- To identify fundamental differences and practical considerations for their application.
Main Methods:
- Analytic derivations and simulation studies were employed.
- Bayesian dynamic borrowing (BDB) approach was examined.
- Digital Twins (DT) method, utilizing prognostic scores from historical data within an ANCOVA framework, was analyzed.
Main Results:
- Both BDB and DT aim to leverage historical data but possess distinct underlying mechanisms.
- A significant concern identified for BDB is the potential inflation of type 1 error rates.
- The tangible benefits of DT in actual randomized clinical trials require further empirical validation.
Conclusions:
- BDB and DT, despite similar goals, have critical differences impacting their suitability for specific RCTs.
- Type 1 error inflation is a notable drawback of BDB that necessitates careful management.
- Further research and evidence are needed to establish the practical value and reliability of DT in real-world clinical trial settings.
More Related Videos
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Bootstrapping
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
Hindsight Biases

